跳至主要内容
临床试验/ITMCTR1900002719
ITMCTR1900002719尚未招募1 期

A random, multi-center controlled trial for Qi-Jing Hui-Xin Decoction in the treatment of microvascular angina

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. Aged 18 years old;
  • 2. It conforms to the diagnostic criteria of smicrovascular angina (CSS angina severity grade I-III);
  • 3. Those who accord with traditional Chinese medical syndrome meet the above TCM syndrome differentiation;
  • 4. Sign informed consent and be Willing to accept Chinese medicine treatment.

排除标准

  • 1. severe heart disease (unstable angina, severe arrhythmia, etc.), Chest pain caused by diseases other than coronary artery disease, such as psychosis, severe neurosis, hyperthyroidism, biliary heart syndrome, gastroesophageal reflux, aortic dissection, etc.;
  • 2. Complicated with uncontrolled grade III hypertension (systolic blood pressure (> 180 mmHg) and/or diastolic blood pressure (> 110 mmHg), severe cardiopulmonary dysfunctionsevere arrhythmia;
  • 3. The patients with liver, kidney, hematopoietic system and other serious diseases, and other serious primary disease;
  • 4. Those who participated in other drug clinical trials within one month;
  • 5. Recently (over 4 weeks) who have undergone major surgery;
  • 6. Pregnancy, lactating women or pregnant planners;
  • 7. Anaphylaxis or allergic to the test drug ingredients1.

研究者

发起方
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验